Thank you to our 2025 NYCACS Surgical Symposium Sponsors!
PLATINUM SPONSOR
Medtronic
GOLD SPONSORS
Garfunkel Wild P.C.
Medtronic
SpringWorks Terapeutics
SILVER SPONSORS
BD-Becton, Dickinson & Company
Organogenesis
EXHIBITORS
ConvaTec
Consigliere Sales Associates
IOM Monitoring Soluations
Telefax
SPONSORS
Weill Cornell Medicine
University of Rochester
We anticipate over 100 surgeons to attend the meeting this year!
The Industry Exhibitor Prospectus Designed for companies that would like a table top display at the meeting. MEETING FORMAT The meeting will take place in-person. EXHIBIT HALL Exhibitors will be set up in the exhibit hall where we willserve meals and snacks during breaks. This room is separatefrom the educational activity. EXHIBIT TIMES The exhibit hall will be open 6am-2pm on Saturday & Sunday,with dedicated exhibit visitation breaks throughout the dayexhibitors can begin setting up on Friday starting at 4pm. Additional Venue Information | Surgical Department and Program Sponsorship Prospectus Designed for surgical programs or departments that would like to support the meeting with recognition but will not have a tabletop display. |
CONTACT INFORMATION
New York Chapter American College of Surgeons
150 State Street, Floor 4
Albany, New York 12207
info@nysurgeon.org or anita@medsci.us
518-953-5401
GOLD SPONSOR
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Targeted oncology has tremendous potential, but underserved patients need new advances, more precise therapies, and better outcomes – right now. So, we relentlessly pursue every possibility to create new paths to cancer breakthroughs. We scrutinize promising molecules from every angle to unlock their full potential, forge partnerships with industry and academic innovators to multiply the opportunities for success, and build our company with people who think hard, care hard and act with urgency. We have a differentiated targeted oncology portfolio and are advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers. We believe in bringing extraordinary tenacity to targeted oncology because people with cancer can’t wait.
Garfunkel Wild For over 40 years, Garfunkel Wild has been committed to meeting the specialized business and legal needs of its clients in the health care industry. With offices in New York, New Jersey, Connecticut, Washington DC, and Florida, Garfunkel Wild is one of the preeminent and largest firms in the country focusing on health care law. Our firm has provided health care, transactional, regulatory, and litigation advice to thousands of physicians, hundreds of hospitals and health care systems, ASCs, long-term care providers and FQHCs, and numerous urgent care centers, telehealth providers, skilled nursing and assisted living facilities, home care agencies, and emerging companies. Our depth of experience and broad scope enable us to offer strategic, knowledgeable, and effective legal solutions to our clients. Garfunkel Wild’s attorneys bring a unique perspective based on their prior professional experience, including former physicians, nurses, risk managers, prosecutors, regulators, in-house counsel, big law alums, among others with practical experience that significantly enhances their legal advice. Our primary focus has always been to help our clients navigate the complex regulatory and business challenges they face on a daily basis. We are built to handle issues with a health care component, anywhere in the country, and integrate closely with clients to provide pragmatic cost-effective solutions.
SILVER SPONSOR
ORGANOGENESIS: From advanced wound care through surgery and sports medicine, we are committed to empowering healing by confidently and reliably delivering clinicians the range of regenerative tissue innovations along with the services they need.
EXHIBITORS
At Teleflex, we believe in empowering clinicians to help save lives through access to innovative and intuitive medical technology. Our portfolio of products, including QuikClot Control+™Hemostatic Devices and the Arrow™ EZ-IO™ System, address the time-critical challenges of controlling severe bleeding and achieving vascular access. More information: www.quikclot.com/trauma and www.teleflex.com/ezio. Rx Only. Safety Info: https://teleflex.link/em-indications
The Department of Surgery at Weill Cornell Medicine is internationally recognized for outstanding and innovative surgical expertise. Our mission is to provide the highest quality, personalized patient care and achieve the most successful surgical outcomes; to discover new medical knowledge and develop advanced, state-of-the-art, minimally invasive techniques and procedures; to preserve and communicate knowledge through education and to nurture and sustain a community of scholars; and to address the health concerns of the community, the region and the nation. The Department is organized into eight divisions. General Surgery the largest division, is comprised of six sections: Breast Surgery; Colon and Rectal Surgery; Endocrine Surgery; Gastrointestinal Metabolic and Bariatric Surgery; Liver Transplantation, Hepatobiliary and Pancreatic Surgery; and Surgical Oncology. Other divisions include Trauma, Burns, Acute and Critical Care; Oral and Maxillofacial Surgery & Dentistry; Pediatric Surgery and Pediatric Trauma; Plastic and Reconstructive Surgery, Transplantation Surgery; Vascular and Endovascular Surgery; and Surgery Research. NewYork-Presbyterian/Weill Cornell Medicine is one of the leading academic medical centers in the world and is one of the hospitals in the honor roll by US News & World Report for 2024-25.